Ahmad M Hassaneen^1,2*

¹Sulaiman AlRajhi University, Al Bukayriyah, Kingdom of Saudi Arabia
²Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

*Corresponding Author: Ahmad M Hassaneen, Sulaiman AlRajhi University, Al Bukayriyah, Kingdom of Saudi Arabia.

Received: March 21, 2022; Published: May 09, 2022

Abstract

Background: Thrombocytopenia is a very common complication in the intensive care unit and is considered an important prognostic factor. The important possible mechanisms for thrombocytopenia include disseminated intravascular coagulation, sepsis, massive hemorrhage, the use of heparin and antibiotics.

Aim of Study: This study aimed to determine the prevalence and risk factors of thrombocytopenia in the medical intensive care unit in Zagazig University hospitals in Egypt.

Patients and Methods: This observational, cross-sectional study was conducted on 140 patients (78 males and 62 females) in the medical intensive care unit. Present and past history was taken, and platelets count was estimated every day until discharge to detect thrombocytopenia.

Results: Thrombocytopenia was detected in 94 patients, with a prevalence of 67% (53 males and 41 females). Regarding age, 56% of cases were above the age of 60 years. The main risk factors for development of thrombocytopenia in this study were sepsis, antibiotics, heparin and mechanical ventilation as there was a significant difference between patients with and those without thrombocytopenia regarding these factors. On the other hand, there was no significant difference regarding duration of ICU stay, invasive catheters or coronary artery disease.

Conclusion: Thrombocytopenia is a common complication in ICU patients. The main risk factors are sepsis, antibiotics, heparin and mechanical ventilation.

Keywords: Thrombocytopenia; Intensive Care Unit; Prevalence; Risk Factors

References

1. Bonfiglio MF., et al. “Thrombocytopenia in intensive care patients: A comprehensive analysis of risk factors in 314 patients”. Annals of Pharmacotherapy9 (1995): 835-842.
2. Khurana D and Deoke SA. “Thrombocytopenia in critically ill patients: clinical and laboratorial behavior and its correlation with short-term outcome during hospitalization”. Indian Journal of Critical Care Medicine 21 (2017): 861-864.
3. Greinacher A and Selleng K. “Thrombocytopenia in the intensive care unit patient”. Hematology ASH Education Program (2010): 135-143.
4. Chang JC. “Thrombocytopenia in critically ill patients due to vascular microthrombotic disease: pathogenesis based on “two activation theory of the endothelium”. Vascular disease Therapy 2 (2017): 1-7.
5. Levi M and Schultz M. “Coagulopathy and platelet disorders in critically ill patients”. Minerva Anestesiology 76 (2010): 851-859.
6. Domingos Dias Cicarelli., et al. “Thrombocytopenia in critically ill patients: prognostic marker in postoperative ICU”. Global Anesthesia and Perioperative Medicine (2015).
7. Andreas Greinacher and Kathleen Selleng. “Thrombocytopenia in the Intensive Care Unit Patient”. Hematology ASH Education Program1 (2010): 135-143.
8. Boechat TD., et al. “Thrombocitopenia in sepsis: an important prognosis factor”. Revista Brasileira de Terapia Intensiva 24 (2012): 35-42.
9. Vanderschueren S., et al. “Thrombocytopenia and prognosis in intensive care”. Critical Care Medicine 28 (2000): 1871-1876.
10. Thiele T., et al. “Thrombocytopenia in the intensive care unit-diagnostic approach and management”. Seminar on Hematology3 (2013): 239-250.
11. Aissaoui Y., et al. “Thrombocytopenia in a surgical intensive care unit: incidence, risk factors and effect on outcome”. Presse Medicine 36 (2007): 43-49.
12. Strauss R., et al. “Thrombocytopenia inpatients in the medical intensive care unit: Bleeding prevalence, transfusion requirements and outcome”. Critical Care Medicine8 (2002): 1765-1771.
13. Sara Rahama., et al. “Prevalence of Intensive-care-unit-acquired Thrombocytopenia in a Tertiary Care Hospital in Sudan”. Sulaiman Al Habib Medical Journal 1.1-2 (2019): 12-15.
14. C MEHTA., et al. “Incidence and risk factors for thrombocytopenia in the intensive care units of a tertiary hospital in northern India”. Southern African Journal of Critical Care1 (2016): 28-31.
15. SO Yeon LIM., et al. “The Incidence, Causes, and Prognostic Significance of New-Onset Thrombocytopenia in Intensive Care Units: A Prospective Cohort Study in a Korean Hospital”. Journal of Korean Medical Science 27 (2012): 1418-1423.
16. Stephan F., et al. “Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock”. Clinical Infectious Disease 25 (1997): 1159-1164.
17. Neame PB., et al. “Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation”. Blood 56 (1980): 88-92.
18. Hanai Y., et al. “A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia”. Journal of Infection and Chemotherapy 22 (2016): 536-542.
19. Williamson DR., et al. “Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes”. Chest 144 (2013): 1207-1215.
20. Warkentin TE., et al. “Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin”. Blood 106 (2005): 3791-3796.

Citation

Citation: Ahmad M Hassaneen. “Prevalence and Risk Factors of Thrombocytopenia in a Medical Intensive Care Unit in Egypt”.Acta Scientific Medical Sciences 6.6 (2022): 96-101.

Copyright

Copyright: © 2022 Ahmad M Hassaneen. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.